Perry Business Support Grant

This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P&F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers.

The Black Ambition Prize competition provides a platform for underrepresented founders across the nation to access growth capital, coaching, and a curated community of innovators and mentors. Eligible applicants consist of diverse innovators building early-stage ventures

REDC offers grants of up to $5,000 for qualifying for-profit New Hampshire businesses with five or fewer employees to purchase equipment or machinery. Grant funding is limited and not guaranteed.

This program will provide a state match to companies that have received a Phase I award through a federal SBIR or STTR grant program. The maximum award under this program may not exceed $50,000. Seventy-five percent (75%) of the total grant shall be remitted to the business upon receipt of the SBIR/STTR Phase I award and application for funds. The remaining twenty-five percent (25%) of the total grant shall be remitted to the business upon submission by the business of the Phase II application to the federal funding agency and acceptance of the Phase I report by the federal funding agency. This program is utilizing state funds appropriated by the Illinois General Assembly to the Department of Commerce and Economic Opportunity.

The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging research into the role of inflammation in cancer is largely based on in vitro and ex vivo methods with limited utilization of imaging approaches that could lead to significant new insights relevant to dynamic cancer and inflammation interactions. Utilization of molecular imaging probes in pre-clinical and clinical investigations for precise temporal resolution at the molecular and cellular level are valuable approaches for identification and characterization of in vivo inflammatory cellular physiology in cancers and of molecular changes in response to treatment. This FOA encourages applications that focus on developing integrated imaging approaches to interrogate the role of inflammation in cancer through strong cross-field collaboration between cancer basic science researchers and imaging scientists. These collaborations are expected to advance science and understanding of cancer inflammation interactions.